These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20133078)

  • 1. Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.
    Debald M; Pölcher M; Flucke U; Walgenbach-Brünagel G; Walgenbach KJ; Höller T; Wolfgarten M; Rudlowski C; Büttner R; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1128-33. PubMed ID: 20133078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
    Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
    Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).
    Polgár C; Van Limbergen E; Pötter R; Kovács G; Polo A; Lyczek J; Hildebrandt G; Niehoff P; Guinot JL; Guedea F; Johansson B; Ott OJ; Major T; Strnad V;
    Radiother Oncol; 2010 Mar; 94(3):264-73. PubMed ID: 20181402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40.
    Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ
    Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
    Niakosari F; Kahn HJ; Marks A; From L
    Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between D2-40-labeled lymphatic vessel invasion and lymph node metastasis of breast cancer].
    Ding GP; Ye CS; Liu MF; Zhen LF; Liao JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2301-3. PubMed ID: 20965831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation.
    Kühr M; Wolfgarten M; Stölzle M; Leutner C; Höller T; Schrading S; Kuhl C; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e541-6. PubMed ID: 21664064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
    Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
    Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
    Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
    Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-40-positive lymphatic vessel invasion is not a poor prognostic factor in stage I lung adenocarcinoma.
    Shimizu K; Funai K; Sugimura H; Sekihara K; Kawase A; Shiiya N
    Pathol Int; 2013 Apr; 63(4):201-5. PubMed ID: 23692420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40.
    Yonemura Y; Endou Y; Tabachi K; Kawamura T; Yun HY; Kameya T; Hayashi I; Bandou E; Sasaki T; Miura M
    Hum Pathol; 2006 Sep; 37(9):1193-9. PubMed ID: 16938525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
    Mohammed RA; Martin SG; Mahmmod AM; Macmillan RD; Green AR; Paish EC; Ellis IO
    J Pathol; 2011 Feb; 223(3):358-65. PubMed ID: 21171081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.